Dome Life Technologies announced long-term peptide ingredient supply partnerships with multiple international pharmaceutical companies, covering innovative drug R&D and diagnostic reagent applications.
Under the agreements, the company will supply high-purity peptide ingredients at medical-grade standards, with flexible scheduling and stable delivery powered by its own synthesis platform. This marks a key step in the company's global expansion and lays the foundation for future joint R&D.
